Difference between revisions of "Part:BBa K3504002"
Ahmed Wael (Talk | contribs) |
Ahmed Wael (Talk | contribs) (→Characterization) |
||
Line 12: | Line 12: | ||
[[Image:MutationChar2.PNG|thumb|right|Figure 2.Mutation identification:Positive mCherry cells was reverse transcribed to cDNA,after that Nsp1 to 4 and the SGP were magnified by seven pairs of primers and amplicons and later on engineered into DNA of the plasmid and changed into E.coli to be amplified. The lower left part schematic illustrates roughly the locations of point mutations in the 5th sort in NSP2 & NSP3.]] | [[Image:MutationChar2.PNG|thumb|right|Figure 2.Mutation identification:Positive mCherry cells was reverse transcribed to cDNA,after that Nsp1 to 4 and the SGP were magnified by seven pairs of primers and amplicons and later on engineered into DNA of the plasmid and changed into E.coli to be amplified. The lower left part schematic illustrates roughly the locations of point mutations in the 5th sort in NSP2 & NSP3.]] | ||
+ | <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /> | ||
+ | We have made simulations using mathematical modelling techniques to characterize the increase in expression when using replicons over traditional methods.<br /><br /> | ||
+ | We also provide Functional characterization of replicons from literature. As This figure shows HIVA-specific T-cell responses after a single immunization with clinical-grade plasmid DNA vaccines between DREP.HIVA and pTHr.HIVA in individual mice immunized by 10 μg of them | ||
+ | [[Image:Replicon_Char.png|thumb|right|Figure 2. Mathematical modelling simulation of Number of positive strand RNA in traditional vaccination vs with the use of self amplifying replicon.]] | ||
+ | [[Image:Replicon_F_Char.png|thumb|left|Figure 1. Functional characterization of replicons from literature. This figure shows HIVA-specific T-cell responses after a single immunization with clinical-grade plasmid DNA vaccines between DREP.HIVA and pTHr.HIVA in individual mice immunized by 10 μg of them.]] | ||
<br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /> | <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /> | ||
Revision as of 19:11, 21 October 2020
nSP3-Eastern equine encephalitis virus
Part Description
Nsp3 is one of four non structural proteins that together forms the main complex responsible for the synthesis positive-sense viral RNAs, results in the synthesis of both the genomic and subgenomic RNAs, of which the subgenomic RNA is produced in excess of the viral genome. Which allows the virus to self-replicate into millions of copies of the virus.
Usage
∼60kDa nsP3 : The functional role of the nsP3 hasn’t been clear throughout history. It still has a primary part in the RNA synthesis as mutations in nsP3 exhibited defects in the start of minus-strand synthesis or subgenomic RNA synthesis. The alphavirus nsP3 protein has three recognized domains: the macrodomain, the alphavirus unique domain (AUD) and the hypervariable region. The macrodomains of CHIKV and VEEV were found to bind to DNA, RNA and polyADP-ribose in addition to exhibiting adenosine diphosphoribose 1′-phosphate phosphatase activity. Genetic manipulations within the AUD have resulted in defects in minus-strand and subgenomic RNA synthesis, polyprotein processing, and neurovirulence where the exact mechanism is not identified up till now. The C-terminal domain of nsP3 is characterized as being hypervariable and this hypervariable domain is shown to be responsible for the formation of virus-species specific complexes in infected cells. At this time it is not clear that the identified interactions of nsP3 with host factors influence viral RNA synthesis or whether they are indicative of another nsP3 function that regulates the host cell environment.
Characterization
We have made simulations using mathematical modelling techniques to characterize the increase in expression when using replicons over traditional methods.
We also provide Functional characterization of replicons from literature. As This figure shows HIVA-specific T-cell responses after a single immunization with clinical-grade plasmid DNA vaccines between DREP.HIVA and pTHr.HIVA in individual mice immunized by 10 μg of them
Improvements
Using information in literature we were able to increase the replicon cloning and functional ability by adding K94E, S243G,E255D,V305M Mutation to NSP3
References
Li, Y., Teague, B., Zhang, Y., Su, Z., Porter, E., Dobosh, B., ... & Weiss, R. (2019). In vitro evolution of enhanced RNA replicons for immunotherapy. Scientific reports, 9(1), 1-10.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 426
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1297
Illegal PstI site found at 426 - 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 1461
Illegal XhoI site found at 1522
Illegal XhoI site found at 1563 - 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 426
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 426
Illegal AgeI site found at 1002
Illegal AgeI site found at 1371 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 1560
Illegal BsaI site found at 1578
Illegal BsaI.rc site found at 1087